Jaideep Dudani
Private Equity Investor at Monograph Capital Advisors (UK) LLP
Jaideep Dudani active positions
| Companies | Position | Start | End |
|---|---|---|---|
Monograph Capital Advisors (UK) LLP
 Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital Advisors (UK) LLP (Monograph Capital) is a private equity and venture capital firm founded in 2021 by Fred Ehrenkranz Cohen and Charles Conn. The firm is headquartered in London, GB. | Private Equity Investor | 30/06/2021 | - |
Career history of Jaideep Dudani
Former positions of Jaideep Dudani
| Companies | Position | Start | End |
|---|---|---|---|
| RELAY THERAPEUTICS, INC. | Corporate Officer/Principal | 31/05/2019 | 29/06/2021 |
Glympse Bio, Inc.
 Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Consultant / Advisor | 31/12/2017 | 30/03/2018 |
Training of Jaideep Dudani
| Massachusetts Institute of Technology | Doctorate Degree |
| University of California, Los Angeles | Undergraduate Degree |
Statistics
International
| United States | 5 |
| United Kingdom | 2 |
Operational
| Private Equity Investor | 1 |
| Corporate Officer/Principal | 1 |
| Consultant / Advisor | 1 |
Sectoral
| Finance | 3 |
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| RELAY THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Monograph Capital Advisors (UK) LLP
Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital Advisors (UK) LLP (Monograph Capital) is a private equity and venture capital firm founded in 2021 by Fred Ehrenkranz Cohen and Charles Conn. The firm is headquartered in London, GB. | Finance |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Jaideep Dudani
- Experience